MENU
MCRB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Seres Therapeutics (MCRB) Ownership - Who owns Seres Therapeutics?
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
101 Cambridgepark Drive
Phone
+1 617 945-9626
Employees
233
Web
https://www.serestherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
170.19M
P/E Ratio
N/A
Total Cash
45.38M
Projected Growth
N/A
Total Debt
87.43M
Revenue
N/A
Risk (Beta)
0.39
Dividend Yield
N/A
Total Cash/Share
5.18
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MCRB
Capitalization
170M
P/E Ratio
N/A
Risk (Beta)
0.39
Dividend Yield
N/A
Total Cash
45.4M
Total Cash/Share
5.18
Total Debt
87.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
33M
P/B Ratio
5.17
Cash Flow
N/A
Earnings
11.28
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
1.57
Current Revenue Per Employee
274.68
Dividends Per Share - Security
N/A
EBITDA
-49.22M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
36.93
Shares Held By Institutions
27.3M
Shares Outstanding - Current
8.76M
Total Liabilities
111M
Total Volume MTD
N/A
Value
N/A
Gain YTD
16.968
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a developer of novel treatments for diseases related to the human microbiome
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
101 Cambridgepark Drive
Phone
+1 617 945-9626
Employees
233
Web
https://www.serestherapeutics.com